Orthopedic Devices Market
Orthopedic Devices Market to Reach $48.1 Billion by 2030
[London, United Kingdom] – [1st June 2023] – The global orthopedic devices market is projected to reach $48.1 billion by 2030, according to a new report by Pharmanucleus. The report, titled “Orthopedic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,” provides an in-depth analysis of the market, including its drivers, restraints, opportunities, and challenges.
The market is driven by the increasing geriatric population, rising incidence of chronic diseases, and growing demand for minimally invasive surgeries. The rising awareness about the importance of early diagnosis and treatment of orthopedic conditions and the increasing adoption of technological advancements in orthopedic devices are also expected to drive the market growth.
However, the high cost of orthopedic devices and the lack of skilled surgeons in developing countries are expected to restrain the market growth.
The report segments the market by product type, application, end user, and region. By product type, the market is segmented into implants, prosthetics, and orthotics. By application, the market is segmented into trauma, sports medicine, and spine. By end user, the market is segmented into hospitals, clinics, and ambulatory surgery centers.
The report also provides a competitive landscape of the market, including the market share of major players such as Stryker, Johnson & Johnson, Zimmer Biomet, Medtronic, and Smith & Nephew.
The report concludes with a SWOT analysis of the market and provides recommendations for the players operating in the market.
For more information about the report and to request a sample copy, please visit
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.